Medical - Devices
Compare Stocks
2 / 10Stock Comparison
ADGM vs ABLV
Revenue, margins, valuation, and 5-year total return — side by side.
Advertising Agencies
ADGM vs ABLV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | Advertising Agencies |
| Market Cap | $15M | $33M |
| Revenue (TTM) | $-143K | $113M |
| Net Income (TTM) | $-75M | $2M |
| Gross Margin | -6.2% | 12.3% |
| Operating Margin | -232.3% | 0.6% |
| Total Debt | $16M | $11M |
| Cash & Equiv. | $21M | $15M |
ADGM vs ABLV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 24 | May 26 | Return |
|---|---|---|---|
| Adagio Medical Hold… (ADGM) | 100 | 18.5 | -81.5% |
| Able View Inc. (ABLV) | 100 | 42.9 | -57.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ADGM vs ABLV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ADGM carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth -10.3%, EPS growth 27.2%, 3Y rev CAGR -0.1%
- Lower volatility, beta 0.87, Low D/E 81.7%, current ratio 3.27x
- Beta 0.87, current ratio 3.27x
ABLV is the clearest fit if your priority is long-term compounding.
- -87.8% 10Y total return vs ADGM's -89.5%
- 2.1% margin vs ADGM's -199.9%
- 0.2% yield; the other pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -10.3% revenue growth vs ABLV's -13.5% | |
| Quality / Margins | 2.1% margin vs ADGM's -199.9% | |
| Stability / Safety | Lower D/E ratio (81.7% vs 157.1%) | |
| Dividends | 0.2% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | -26.1% vs ABLV's -48.1% | |
| Efficiency (ROA) | 5.4% ROA vs ADGM's -189.8% |
ADGM vs ABLV — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ABLV leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ABLV and ADGM operate at a comparable scale, with $113M and -$143,000 in trailing revenue. ABLV is the more profitable business, keeping 2.1% of every revenue dollar as net income compared to ADGM's -199.9%. On growth, ABLV holds the edge at -25.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | -$143,000 | $113M |
| EBITDAEarnings before interest/tax | -$67M | $902,648 |
| Net IncomeAfter-tax profit | -$75M | $2M |
| Free Cash FlowCash after capex | -$24M | $3M |
| Gross MarginGross profit ÷ Revenue | -6.2% | +12.3% |
| Operating MarginEBIT ÷ Revenue | -232.3% | +0.6% |
| Net MarginNet income ÷ Revenue | -199.9% | +2.1% |
| FCF MarginFCF ÷ Revenue | -115.6% | +2.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | -25.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -106.3% | +97.8% |
Valuation Metrics
ABLV leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $15M | $33M |
| Enterprise ValueMkt cap + debt − cash | $10M | $29M |
| Trailing P/EPrice ÷ TTM EPS | -0.27x | -3.72x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 54.49x | 0.26x |
| Price / BookPrice ÷ Book value/share | 0.73x | 3.95x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
ABLV leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
ABLV delivers a 27.9% return on equity — every $100 of shareholder capital generates $28 in annual profit, vs $-8 for ADGM. ADGM carries lower financial leverage with a 0.82x debt-to-equity ratio, signaling a more conservative balance sheet compared to ABLV's 1.57x. On the Piotroski fundamental quality scale (0–9), ADGM scores 4/9 vs ABLV's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -7.5% | +27.9% |
| ROA (TTM)Return on assets | -189.8% | +5.4% |
| ROICReturn on invested capital | — | -81.3% |
| ROCEReturn on capital employed | -374.1% | -25.4% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 2 |
| Debt / EquityFinancial leverage | 0.82x | 1.57x |
| Net DebtTotal debt minus cash | -$4M | -$4M |
| Cash & Equiv.Liquid assets | $21M | $15M |
| Total DebtShort + long-term debt | $16M | $11M |
| Interest CoverageEBIT ÷ Interest expense | -36.69x | -22.79x |
Total Returns (Dividends Reinvested)
ABLV leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ABLV five years ago would be worth $1,218 today (with dividends reinvested), compared to $1,053 for ADGM. Over the past 12 months, ADGM leads with a -26.1% total return vs ABLV's -48.1%. The 3-year compound annual growth rate (CAGR) favors ABLV at -50.4% vs ADGM's -52.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -11.8% | -0.4% |
| 1-Year ReturnPast 12 months | -26.1% | -48.1% |
| 3-Year ReturnCumulative with dividends | -89.5% | -87.8% |
| 5-Year ReturnCumulative with dividends | -89.5% | -87.8% |
| 10-Year ReturnCumulative with dividends | -89.5% | -87.8% |
| CAGR (3Y)Annualised 3-year return | -52.8% | -50.4% |
Risk & Volatility
ABLV leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ABLV is the less volatile stock with a -0.46 beta — it tends to amplify market swings less than ADGM's 0.87 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.87x | -0.46x |
| 52-Week HighHighest price in past year | $2.58 | $1.77 |
| 52-Week LowLowest price in past year | $0.74 | $0.54 |
| % of 52W HighCurrent price vs 52-week peak | +36.9% | +37.9% |
| RSI (14)Momentum oscillator 0–100 | 37.3 | 51.4 |
| Avg Volume (50D)Average daily shares traded | 124K | 314K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
ABLV is the only dividend payer here at 0.21% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | $0.00 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.6% |
ABLV leads in 5 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics.
ADGM vs ABLV: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is ADGM or ABLV a better buy right now?
For growth investors, Adagio Medical Holdings, Inc.
(ADGM) is the stronger pick with -10. 3% revenue growth year-over-year, versus -13. 5% for Able View Inc. (ABLV). The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ADGM or ABLV?
Over the past 5 years, Able View Inc.
(ABLV) delivered a total return of -87. 8%, compared to -89. 5% for Adagio Medical Holdings, Inc. (ADGM). Over 10 years, the gap is even starker: ABLV returned -87. 8% versus ADGM's -89. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ADGM or ABLV?
By beta (market sensitivity over 5 years), Able View Inc.
(ABLV) is the lower-risk stock at -0. 46β versus Adagio Medical Holdings, Inc. 's 0. 87β — meaning ADGM is approximately -291% more volatile than ABLV relative to the S&P 500. On balance sheet safety, Adagio Medical Holdings, Inc. (ADGM) carries a lower debt/equity ratio of 82% versus 157% for Able View Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — ADGM or ABLV?
By revenue growth (latest reported year), Adagio Medical Holdings, Inc.
(ADGM) is pulling ahead at -10. 3% versus -13. 5% for Able View Inc. (ABLV). On earnings-per-share growth, the picture is similar: Adagio Medical Holdings, Inc. grew EPS 27. 2% year-over-year, compared to -175. 0% for Able View Inc.. Over a 3-year CAGR, ABLV leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ADGM or ABLV?
Able View Inc.
(ABLV) is the more profitable company, earning -5. 8% net margin versus -199. 9% for Adagio Medical Holdings, Inc. — meaning it keeps -5. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ABLV leads at -6. 8% versus -232. 3% for ADGM. At the gross margin level — before operating expenses — ABLV leads at 9. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — ADGM or ABLV?
In this comparison, ABLV (0.
2% yield) pays a dividend. ADGM does not pay a meaningful dividend and should not be held primarily for income.
07Is ADGM or ABLV better for a retirement portfolio?
For long-horizon retirement investors, Able View Inc.
(ABLV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 46)). Both have compounded well over 10 years (ABLV: -87. 8%, ADGM: -89. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between ADGM and ABLV?
These companies operate in different sectors (ADGM (Healthcare) and ABLV (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.